Anesthesia, pain management and perioperative intensive care: To develop new procedures for improving safety and efficacy in anesthesic procedures, and to investigate the multiple problems of pain management and anaesthesia support.

Vascular anomalies: To investigate genetic and molecular mechanisms involved in the pathogenesis of vascular anomalies, and to evaluate new treatments.

Cardiovascular surgery: To assess different organ perfusion devices and to develop new strategies for graft perfusion.

Congenital malformations: To gain knowledge on the cellular and molecular mechanisms of malformations using animal models, organ and cell cultures and eventually genetically engineered animals.

Oftalmologic pathology: To investigate genetic and molecular mechanisms involved in the pathogenesis of ocular malformations and ocular rare diseases.

Transplantation: To investigate new strategies for graft tolerance/avoidance of rejection and to analyze the impact of donation after circulatory death with normothermic reperfusion in pediatric transplantation. Additionally, the management of the conditions leading to organ failure would be included in our topics, like intestinal rehabilitation (intestinal transplantation), liver tumours (liver transplantation) and severe uropathies (renal transplantation).

Scientific Objectives

Planned Research Projects

Anesthesia: We shall center our interest on safe hemoderivatives transfusion and metabolic monitoring during complex surgical procedures. Also quality initiatives will be included in our scope.

Vascular anomalies: We will continue with our recent project focused on the long-term safety and efficacy of alpelisib in patients with PIK3CA-Related Overgrowth Spectrum (PROS); and we will improve our contribution to our lymphatic malformation program.

Cardiovascular surgery: We plan to initiate our research on mitochondrial transplantation to improve recovery after infarction. We will also continue our hemodynamic assessment of ex vivo perfusion devices. In the clinic, we will prospectively analyze the recently developed program of heart transplantation from DCD.

Congenital malformations: We will deepen our study of fetal alcohol syndrome. More specifically, we aim at further investigating the participation of antioxidant agents. We will also try to gain further insight into instrumental prenatal manipulation in Spina Bifida in collaboration with the research group of Cincinnati Children Hospital.

Ocular pathology: We will continue our open research line of genetic study on congenital non syndromic bilateral cataracts and myopia with or without nistagmus.

Transplantation: Finally, as the only group involved in pediatric small bowel transplantation in Spain, we shall also continue our efforts for improving the graft viability, to deepen our understanding of rejection and GVHD phenomenons and for searching tolerance by different cell therapies.. All this work in animal models will be complemented with human studies on liver and small bowel material .

Anesthesia, pain management and perioperative intensive care: To develop new procedures for improving safety and efficacy in anesthesic procedures, and to investigate the multiple problems of pain management and anaesthesia support.

Vascular anomalies: To investigate genetic and molecular mechanisms involved in the pathogenesis of vascular anomalies, and to evaluate new targeted therapies

Cardiovascular surgery: To assess different organ perfusion devices and to develop new strategies for graft perfusion.

Congenital malformations: To gain knowledge on the cellular and molecular mechanisms of malformations using animal models, organ and cell cultures and eventually genetically engineered animals.

Oftalmologic pathology: To investigate genetic and molecular mechanisms involved in the pathogenesis of ocular malformations and ocular rare diseases.

Transplantation: To investigate new strategies for graft tolerance/avoidance of rejection and to analyze the impact of donation after circulatory death with normothermic reperfusion in pediatric transplantation. Additionally, the management of the conditions leading to organ failure would be included in our topics, like intestinal rehabilitation (intestinal transplantation), liver tumours (liver transplantation) and severe uropathies (renal transplantation).